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ystic ﬁbrosis (CF) is a childhood hereditary disease
in which the most common mutant form of the
CF transmembrane conductance regulator (CFTR)
 
 
 
F508 fails to exit the endoplasmic reticulum (ER). Export
of wild-type CFTR from the ER requires the coat complex II
(COPII) machinery, as it is sensitive to Sar1 mutants that
disrupt normal coat assembly and disassembly. In con-
trast, COPII is not used to deliver CFTR to ER-associated
C
 
degradation. We ﬁnd that exit of wild-type CFTR from
the ER is blocked by mutation of a consensus di-acidic ER
exit motif present in the ﬁrst nucleotide binding domain.
Mutation of the code disrupts interaction with the COPII
coat selection complex Sec23/Sec24. We propose that
the di-acidic exit code plays a key role in linking CFTR
to the COPII coat machinery and is the primary defect re-
sponsible for CF in 
 
 
 
F508-expressing patients.
 
Introduction
 
The cystic fibrosis (CF) transmembrane conductance regulator
(CFTR) is a cAMP-regulated chloride channel found in the apical
membrane of polarized epithelia lining many tissues including
the intestine, pancreas, and lung (for reviews see Kopito, 1999;
Riordan, 1999; Bertrand and Frizzell, 2003). Although more
than 1,000 mutations have been identified in the CFTR gene,
 
 
 
F508 accounts for nearly 70% of CF alleles. In homozygous
individuals, the 
 
 
 
F508-CFTR mutation leads to severe forms of
CF. CFTR contains 12 transmembrane domains and three cyto-
solic oriented domains (nucleotide binding domain 1 [NBD1],
R, and NBD2) involved in channel gating. Current evidence
suggests that deletion of Phe508 in NBD1 prevents proper fold-
ing and trafficking of CFTR from the ER to the plasma mem-
brane (Kopito, 1999; Riordan, 1999; Bertrand and Frizzell,
2003). 
 
 
 
F508-CFTR is a temperature-sensitive mutant, as trans-
fer to the permissive temperature (27–30
 
 
 
C) results in partial
export from the ER (Denning et al., 1992; French et al., 1996).
Misfolded 
 
 
 
F508-CFTR that fails to exit the ER is eliminated
by the ER-associated degradation (ERAD) pathway (Xiong et
al., 1999; Gelman et al., 2002; Lenk et al., 2002).
Export from the ER now appears to involve specific exit
codes that couple cargo to a common cytosolic budding
machinery (Barlowe, 2003). A conserved di-acidic exit code
found in the cytosolic tail of many type I transmembrane pro-
teins was first identified in mammalian cells (Nishimura and
Balch, 1997; Nishimura et al., 1999; Sevier et al., 2000) and
subsequently in yeast (Votsmeier and Gallwitz, 2001; Malkus
et al., 2002). The di-acidic code directs selective (Balch et al.,
1994) and efficient (Nishimura and Balch, 1997; Nishimura et
al., 1999) ER export by promoting interaction of cargo with the
coat complex II (COPII) budding machinery. COPII (for review
see Antonny and Schekman, 2001) consists of the Sar1 GTPase,
the cargo selection protein complex Sec23/24 that is a Sar1-
specific guanine nucleotide activating protein (GAP; Aridor et
al., 1998; Miller et al., 2002), and a coat polymer assembly
factor, Sec13/31 (Pryer et al., 1993; Antonny et al., 2001,
2003). The Sar1 GTPase is recruited and activated by the ER-
localized transmembrane protein Sec12, a guanine nucleotide
exchange factor specific for Sar1 (Barlowe and Schekman,
1993; Weissman et al., 2001). Sar1 activation is essential for
recruitment of the Sec23/24 complex to the ER membrane to
select cargo and to initiate COPII coat assembly.
Assembly and disassembly of the COPII coat can be
rigorously controlled in vivo and in vitro by use of biochemically
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characterized Sar1 mutants. Sar1[T39N] (referred to as Sar1-
GDP) is restricted to the GDP-bound state and biochemically
functions as a competitive inhibitor of wild-type Sar1 recruit-
ment, thereby preventing Sec23/24 attachment to the ER mem-
brane and coat assembly (Kuge et al., 1994; Weissman et al.,
2001). Sar1[H79G] (referred to as Sar1-GTP) has a reduced
rate of GAP-stimulated hydrolysis, remaining in the GTP-
bound state after activation. Although efficiently recruited to
the ER membrane where it promotes cargo recruitment and the
assembly of coat polymers, its inability to undergo hydrolysis
interferes with subsequent COPII coat disassembly, resulting in
inhibition of ER to Golgi transport (Kuge et al., 1994; Aridor et
al., 1998, 2001; Huang et al., 2001). In addition, we have dem-
onstrated that the protein kinase inhibitor H89 blocks recruit-
ment of COPII coat components and prevents vesicle forma-
tion from the ER (Aridor and Balch, 2000). These probes
provide powerful approaches to dissect the role of COPII func-
tion in transport of cargo through the secretory pathway.
To develop a therapeutic means to stimulate 
 
 
 
F508-
CFTR trafficking from the ER to the cell surface, it is neces-
sary to understand the mechanisms and pathways that regulate
its export from the ER. We have previously shown that CFTR
exits the ER in a COPII-dependent fashion (Yoo et al., 2002).
A recent paper (Fu and Sztul, 2003) proposed that COPII also
regulates the delivery of wild-type CFTR to the ERAD path-
way in the yeast 
 
Saccharomyces cerevisiae
 
 (Xiong et al., 1999;
Gelman et al., 2002; Lenk et al., 2002). We have now exam-
ined in detail the contribution of COPII to the export of CFTR
to the Golgi and its potential contribution to the ERAD path-
way in mammalian cells. Our results demonstrate that although
COPII is essential for export of wild-type CFTR from the ER,
we found no evidence that COPII contributes to the targeting of
either wild-type CFTR or the 
 
 
 
F508-CFTR mutant to ERAD
pathway. Intriguingly, we report that export of CFTR is highly
sensitive to mutation of a highly conserved, consensus di-
acidic exit code (Nishimura and Balch, 1997) found in the
NBD1 domain of CFTR. We find that coupling to the Sec23/24
cargo selection complex through the di-acidic code is critical
for diverting CFTR from the ERAD pathway. We propose that
the di-acidic exit code plays a key role in linking CFTR to the
COPII coat machinery and is the primary defect leading to dis-
ease in 
 
 
 
F508-expressing patients.
 
Results
 
Degradation of wild-type CFTR is COPII 
independent
 
To follow export of CFTR from the ER, baby hamster kidney
(BHK) cells were transfected with CFTR using a vaccinia-tran-
sient expression system, pulse-labeled with [
 
35
 
S]methionine,
and CFTR transport to the Golgi detected by processing of the
band B N-linked core-oligosaccharide form to the band C com-
plex form by Golgi-associated glycosyltransferases that has re-
duced migration on SDS-PAGE (Yoo et al., 2002; Fig. 1 A, in-
set, CFTR mock). In most tissue culture cell lines engineered to
express CFTR, wild-type CFTR is inefficiently exported, re-
sulting in processing of only 20–30% of the ER-associated
band B to the Golgi-and post-Golgi mature band C form (Fig. 1
A, inset and bottom left panel; Riordan, 1999). CFTR failing to
exit the ER is degraded by ERAD indicated by the loss of band
B (Fig. 1 A, inset and top panel; Xiong et al., 1999; Gelman et
al., 2002; Lenk et al., 2002).
We have previously reported (Yoo et al., 2002) that Golgi
processing of band B to band C is inhibited by cotransfection
with the Sar1-GTP mutant when overexpressed 
 
 
 
5–10-fold,
demonstrating that CFTR exits the ER by a COPII-dependent
pathway (Fig. 1 A, inset and bottom panels). Inhibition is
clearly evident in the ratio of band C to band B (C/B ratio).
When compared with the mock control C/B value of 
 
 
 
1.8 at
the 3-h time point, the C/B ratio in the presence of Sar1-GTP
was 
 
 
 
0.2 (Fig. 1 A, bottom right panel). To pursue the possi-
bility that COPII is required for ER export but not ERAD, we
examined the effect of the Sar1-GDP mutant that is restricted to
the GDP-bound form on CFTR glycosylation or proteolysis. As
Sar1-GDP is a competitive inhibitor of recruitment of wild-type
Sar1 to the Sec12 guanine nucleotide exchange factor (Weiss-
man et al., 2001) and Sar1 activation is essential for the recruit-
ment of the cargo selection Sec23/24 complex to the ER mem-
brane (Kuge et al., 1994; Weissman et al., 2001), Sar1-GDP
competes with wild-type Sar1 to competitively reduce the effi-
ciency of both COPII recruitment and coat assembly. Although
cotransfection of wild-type CFTR with Sar1-GDP (
 
 
 
5–10-fold
overexpression; Kuge et al., 1994; Yoo et al., 2002) strongly in-
hibited export as measured by processing of band B to band C
(Fig. 1 A, inset and bottom panels, C/B ratio is 
 
 
 
0.7), wild-
type CFTR continued to be degraded efficiently in the presence
of the mutant (Fig. 1 A, inset and top panels). Identical results
were observed at both early and late time points of transfection
(unpublished data), indicating that the potential accumulation
of other cargo in the ER in the presence of Sar1-GDP is un-
likely to influence the effect of the Sar1-GDP on CFTR traf-
ficking and degradation. In contrast to Sar1-GDP, Sar1-GTP is
a dominant-negative mutant that promotes cargo collection into
stable COPII-coated intermediates. As a consequence, targeting
and fusion of these intermediates to the Golgi is blocked (Kuge
et al., 1994; Aridor et al., 1998, 2001; Huang et al., 2001). In-
terestingly, cotransfection of wild-type CFTR with Sar1-GTP
significantly (P 
 
  
 
0.05) protected immature (band B) wild-type
CFTR from degradation by the ERAD pathway when com-
pared with degradation rate observed in the presence of the
Sar1-GDP mutant (Fig. 1 A, inset and top panels). This result
raises the possibility that recruitment of CFTR to the assem-
bling COPII polymer at ER exit sites prevents access to ERAD.
We also examined the effects of both Sar1-GDP– and
Sar1-GTP–restricted mutants on 
 
 
 
F508-CFTR stability given
that this protein is not exported from the ER and therefore com-
pletely degraded by ERAD (Fig. 1 B). Cotransfection of
 
 
 
F508-CFTR with the Sar1-GTP–restricted mutant did not
promote processing of band B to C (Fig. 1 B, inset and bottom
panel), nor did it affect the kinetics of degradation by ERAD
(Fig. 1 B, inset and top panel). An identical result was observed
with the Sar1-GDP–restricted mutants (Fig. 1 B). These results
are consistent with the idea that failure to export from the ER
reflects the inability of 
 
 
 
F508 to link to COPII. 
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To provide additional evidence for the role of Sar1 in se-
lection of wild-type CFTR for export, we took advantage of the
protein kinase inhibitor H89 that we have previously shown to
inhibit Sar1 recruitment and COPII coat assembly (Aridor and
Balch, 2000). Addition of H89 to cells stably expressing CFTR
strongly reduced export (90%; Fig. 2). ERAD continues effi-
ciently, suggesting that COPII recruitment is not required for
targeting for degradation as H89, like Sar1-GDP, uncouples
cargo from the COPII coat machinery (Aridor and Balch, 2000).
We conclude that conditions that enhance COPII assem-
bly on the ER membrane stabilize wild-type CFTR from ERAD.
In contrast, conditions that interfere with COPII recruitment
prevent the export of wild-type CFTR, but have little effect on
delivery of either wild-type CFTR or 
 
 
 
F508-CFTR to the
ERAD pathway. Thus, the ERAD pathway functions largely
independently of the COPII machinery.
 
Export, but not ERAD, is reversibly 
sensitive to a novel Sar1 temperature-
sensitive (Sar1
 
ts
 
) mutant
 
To ensure that the aforementioned results with the Sar1 mu-
tants were not a consequence of targeting of either wild-type or
mutant CFTR to a nonphysiological pathway, or reflect indirect
effects of other cargo in the ER on CFTR export or stability, we
developed a temperature-sensitive variant of Sar1. This mutant
is dominant-negative at the permissive temperature (32
 
 
 
C),
where it is folded properly. It loses this dominant-negative ac-
tivity when transferred to the restrictive temperature (40
 
 
 
C),
where it misfolds. When cotransfected with the type 1 trans-
membrane protein vesicular stomatitis virus glycoprotein (VSV-G)
at 32
 
 
 
C, Sar1
 
ts
 
 shows strong inhibition of processing of VSV-G
from the endoglycosidase H (endo H)–sensitive ER form to the
endo H–resistant Golgi form (Fig. 3 A), indicative of an ER to
Figure 1. Export of CFTR from the ER is COPII dependent. BHK cells were transfected with pcDNA3.1 plasmids containing either wild-type CFTR or
 F508-CFTR or cotransfected with pcDNA3.1 containing the indicated Sar1 mutants as described previously (Yoo et al., 2002). After a 30-min pulse with
[
35S]Met, CFTR was immunoprecipitated at the indicated chase time and quantitated using a Molecular Dynamics PhosphoImager as described previously
(Yoo et al., 2002). Expression levels of Sar1 mutants ( 5–10-fold endogenous) were monitored by immunoblotting with specific antibody as described
previously (Yoo et al., 2002; not depicted). (A and B, top panels) Quantitation of CFTR in band B (ER form) reported as a percentage of total B plus C at
the 0 time point. (A and B, bottom panels) Quantitation of the CFTR band C glycosylated form reported as a percentage of total B plus C at the 0 time
point. Insets in A and B show representative autoradiographs containing band B and C (arrows). In A (top right panel), a significant increase in amount of
band B remaining in six independent experiments for cells transfected with Sar1-GTP compared with Sar1-GDP at 3 h is shown (P   0.05). The error bars
represent SEM. The dashed horizontal line indicates the level of band B remaining in the wild-type (mock) control. In A (bottom right panel), the C/B ratios
are shown for the 3-h time point. Results in A and B are typical of at least three independent experiments. 
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Golgi transport block. In contrast, at 40
 
 
 
C, a condition that pro-
motes destabilization of the mutant protein, inhibition of export
is lost (Fig. 3 A). Thus, Sar1
 
ts
 
 shows a thermoreversible tem-
perature-sensitive ER export block.
Transient coexpression of Sar1
 
ts
 
 and wild-type CFTR at
32
 
 
 
C significantly inhibited the export of wild-type CFTR
when compared with the mock control as measured by process-
ing from the band B to the band C forms (Fig. 3 B, bottom right
panel, C/B ratio is 
 
 
 
0.5 at 3 h). Sar1
 
ts
 
 had no apparent effect on
stabilizing wild-type CFTR from degradation at 32
 
 
 
C (Fig. 3 B,
top panel), which is consistent with the interpretation that
Sar1
 
ts
 
 interferes with COPII coat assembly but does not affect
ERAD pathways. Moreover, cotransfection of 
 
 
 
F508-CFTR
with Sar1
 
ts
 
 had no effect on either 
 
 
 
F508-CFTR export or deg-
radation when compared with the controls expressing 
 
 
 
F508
alone at either 32
 
 
 
or 40
 
 
 
C temperatures (unpublished data). Im-
portantly, we used a two-stage incubation protocol to examine
the ability of CFTR to be exported from the ER after accumula-
tion in the presence of the Sar1
 
ts
 
 mutant at 32
 
 
 
C. Cells trans-
fected for 14 h at 32
 
 
 
C to prevent CFTR export were labeled
Figure 2. Export of CFTR from the ER but not degradation is inhibited by
the kinase inhibitor H89. BHK cells stably expressing either wild-type
CFTR or  F508-CFTR were labeled with [
35S]Met for 30 min as described
previously (Yoo et al., 2002). After labeling, cells were chased for the
indicated time in the absence or presence of 50  M H89, and processing
of CFTR from the band B ER form to mature band C was quantitated as
described previously (Yoo et al., 2002). Results are typical of two inde-
pendent experiments.
Figure 3. ER export is reversibly sensitive to a novel Sar1 temperature-
sensitive (Sar1
ts) mutant. (A) BHK cells were cotransfected with pcDNA3.1
containing either VSV-G or VSV-G and the indicated Sar1 mutant. The effect
of Sar1-GTP (control) or Sar1
ts on processing of VSV-G from the endogly-
cosidase H–sensitive (endo H
s) ER form to the endo H–resistant (endo H
r)
Golgi form after a 5-min pulse with [
35S]Met at 32 C followed by a 30
min chase at the indicated temperature was determined as described
previously (Yoo et al., 2002). (B) BHK cells were cotransfected with
pcDNA3.1 containing wild-type CFTR either with vector only (mock) or,
where indicated, cotransfected with pcDNA3.1 containing the Sar1
ts mutant.
The transport and processing of CFTR from band B to C was followed at
the indicated temperature as described in Fig. 1. The C/B ratios for the
Sar1
ts mutant at 32 and 40 C are shown for the 3-h time point. The asterisk
in the top panel of B indicates that CFTR is exported very inefficiently from
the ER as band C is only weakly processed to early Golgi oligosaccharide
forms. White lines indicate that intervening lanes have been spliced out.
Results are typical of three independent experiments. 
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for 30 min at 32
 
 
 
C (stage 1). Subsequently, cells were trans-
ferred to 40
 
 
 
C (stage 2) to inactivate Sar1
 
ts
 
. In contrast to incu-
bation at 32
 
 
 
C (Fig. 3 B, bottom right panel, C/B ratio is 
 
 
 
0.5
at 3 h), upon transfer to 40
 
 
 
C we observed normal processing
of wild-type CFTR from band B to C (Fig. 3 B, bottom right
panel, C/B ratio is 
 
 
 
4 at 3 h). Thus, reversible inhibition of
processing of wild-type CFTR to band C imposed by incuba-
tion at 32
 
 
 
C in the presence of Sar1
 
ts
 
 interferes with the normal
physiological pathway required for COPII-dependent export
but not degradation.
 
CFTR uses a di-acidic exit code for 
export from the ER
 
To understand the requirement for COPII in the export of
CFTR from the ER, we examined the CFTR sequence for the
presence of the evolutionarily conserved tyrosine-based di-
acidic code required for export of VSV-G (Nishimura and
Balch, 1997; Nishimura et al., 1999; Sevier et al., 2000) and
other transmembrane proteins from the ER in mammalian cells
(Bannykh and Balch, 1998; Bannykh et al., 1998) and yeast
(Votsmeier and Gallwitz, 2001; Malkus et al., 2002). Notably,
CFTR contained a YKDAD motif (residues 563 to 567) in the
first nucleotide binding motif (NBD1) that is evolutionarily
conserved and similar to that found in VSV-G (YxDxE; Nish-
imura and Balch, 1997; Sevier et al., 2000). The structure of
the NBD1 domain of CFTR (1ROZ.pdb) reveals that the
YKDAD motif is located in a surface-exposed loop linking the
NH
 
2
 
-terminal helical domain containing Phe508 to the COOH-
terminal sheet domain (Lewis et al., 2004; Fig. 4 A). Strikingly,
transient expression of CFTR mutants in which either one
(DAA-CFTR; Fig. 4 B, inset and bottom panel) or both (AAA-
CFTR; unpublished data) conserved Asp residues were mu-
tated to Ala resulted in complete inhibition of export from the
ER as measured by the inability of band B to be processed to
Figure 4. CFTR uses a di-acidic code for export
from the ER. (A) Location of Phe508 and the
di-acidic code in the NBD1 domain of CFTR
(Lewis et al., 2004; 1ROX.pdb). Shown in
blue is Phe508; shown in red (carbon back-
bone) and yellow (side-chains) is the orientation
of residues Asp565 and Asp567 (di-acidic
code). (B) Cells were either transfected or
cotransfected with the indicated wild-type or
mutant CFTR and the Sar1-GTP mutant as indi-
cated. Processing from band B to band C was
quantitated as described in Fig. 1. (C) Effect
of BFA on stability of wild-type CFTR,  F508-
CFTR, or the DAA-CFTR mutant in the ER.
White lines indicate that intervening lanes have
been spliced out. Cells were pulse-labeled for
30 min with [
35S]Met at 37 C. 10  g/ml BFA
was added and incubation continued for 3 h
at 37 C. (lanes a, d, and g) Total CFTR found
in band B after pulse (expressed as a value of
100%). (lanes b, e, and h) Fraction of CFTR
found in band B after 3-h incubation in the
absence of BFA. (lanes c, f, and i) Fraction of
CFTR found in band B after 3-h incubation in
the presence of BFA. The dashed bar in lane b
indicates the total B   C at the 3-h time point
in the absence of BFA. Results are typical of at
least two independent experiments for each
condition shown. 
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band C and a morphological distribution consistent with local-
ization to the ER (Bannykh et al., 2000; unpublished data).
Like 
 
 
 
F508-CFTR, cotransfection with Sar1-GTP failed to
promote export or stabilize DAA-CFTR from ERAD, suggest-
ing that mutation of the di-acidic motif uncoupled CFTR from
COPII (Fig. 4 B). We also examined whether or not, like
 
 
 
F508-CFTR, the DAA-CFTR phenotype is temperature-sen-
sitive by examining its rate of export at the lowered tempera-
ture (30
 
 
 
C). Whereas transfer of 
 
 
 
F508-CFTR to 30
 
 
 
C resulted
in significant enhancement of transport to the cell surface re-
flecting its effect on conformational stability of NBD1 as ob-
served previously (Denning et al., 1992; French et al., 1996),
we did not observe a similar increase in DAA-CFTR export at
30
 
 
 
C (unpublished data). These results suggest that the DAA
mutation does not affect the fold of NBD1 in a similar fashion
to the 
 
 
 
F508 mutation that can be stabilized by incubation at
reduced temperature.
To further characterize the biochemical properties of the
DAA-CFTR mutant, we took advantage of the previous obser-
vation that treatment of CFTR-expressing cells with brefeldin
A (BFA) reduces degradation of wild-type CFTR, but not
 
 
 
F508-CFTR (Ostedgaard et al., 1999). BFA triggers the col-
lapse of the Golgi to the ER by preventing the recruitment of
coat complex I to Golgi membranes (for review see Chardin
and McCormick, 1999). In contrast to its potent effect on coat
complex I function in the Golgi, BFA has no effect on COPII
function during ER export. As a consequence, in BFA-treated
cells ER-associated cargo is collected in export intermediates
that accumulate in the absence of functional Golgi compart-
ments (Lippincott-Schwartz et al., 1989). As expected, addition
of BFA prevented processing of wild-type CFTR from band B
to C and partially stabilized wild-type CFTR from ERAD,
likely reflecting recruitment to COPII intermediates (Fig. 4 C;
Lukacs et al., 1994; Ward and Kopito, 1994). In contrast, BFA
did not prevent degradation of either the 
 
 
 
F508- or the DAA-
CFTR mutant (Fig. 4 C). These results are consistent with the
interpretation that both mutants fail to couple to the COPII ma-
chinery (Nishimura and Balch, 1997; Nishimura et al., 1999),
resulting in their delivery to the ERAD pathway.
 
The biochemical interaction of CFTR with 
COPII is disrupted by the 
 
 
 
F508 and 
DAA mutations
 
Although the results described in the previous section raise the
possibility that CFTR may exit the ER through the di-acidic
code, it remained to be shown that wild-type CFTR can engage
the COPII machinery and whether interaction with COPII can
be disrupted by the 
 
 
 
F508- or DAA-CFTR mutations. For this
purpose, we first examined the ability of CFTR to bind the
Sec23/Sec24 cargo selection complex in immunoprecipitates
recovered from detergent lysates of HEK293 cell lines stably
expressing either wild-type CFTR or 
 
 
 
F508-CFTR. As shown
in Fig. 5 A, in cells expressing wild-type CFTR, the protein is
largely in the band C mature form with  5% in the band B ER
Figure 5. Wild-type CFTR but not DAA-CFTR binds
COPII. (A) HEK293 stably expressing wild type or  F508
were lysed in the presence of 1% Triton X-100, and
Sec23/Sec24 complex recovered by immunoprecipitation
with a CFTR-specific mAb was quantitated as described
in Materials and methods. CFTR (bands B and C) and
Sec24 were detected by immunoblotting with specific
antibody as described in Materials and methods. (B) As
in A except the amount CFTR recovered by immuno-
precipitation with a Sec24-specific polyclonal antibody
was quantitated as described in Materials and methods
using immunoblotting. HEK293 cells not expressing CFTR
were used as a control. CFTR (bands B and C) were de-
tected by immunoblotting with specific antibody. (C)
HEK293 cells were transfected with pcDNA3.1 plasmids
containing either wild-type CFTR or DAA-CFTR as de-
scribed previously (Yoo et al., 2002). Cells were lysed in
the presence of 1% Triton X-100, and the amount of
Sec23/Sec24 complex recovered bound to band B of
CFTR (expressed as a Sec24/band B ratio) was quanti-
tated as described in Materials and methods. CFTR
(bands B and C) and Sec24 were detected by immuno-
blotting with specific antibodies. (D) HEK293 stably
expressing wild type or  F508 incubated at 37 C (wild
type) or for the indicated time at 30 C ( F508) were
lysed in the presence of 1% Triton X-100, and the
amount of Sec23/Sec24 complex recovered bound to
CFTR by immunoprecipitation with a CFTR-specific anti-
body was quantitated as described in Materials and
methods. Error bars indicates the SD for samples gener-
ated for each time point in triplicate.COPII-DEPENDENT EXPORT OF CFTR • WANG ET AL. 71
form, an expected result given that wild-type CFTR accumu-
lates in post-Golgi compartments. In contrast, in  F508-
CFTR–expressing HEK293 cells, the only form is band B re-
flecting its ER localization, its level of expression reflecting
continuous degradation by ERAD (Fig. 5 A). Despite the large
difference in the steady-state level of CFTR in wild-type and
 F508-expressing cells, when we quantitated the recovery of
Sec24 with respect to the total amount of wild-type CFTR or
 F508-CFTR in band B using immunoblotting, we observed
that  F508-CFTR bound  25% of that observed for wild-type
CFTR (Fig. 5 A). Sec24 was not recovered from HEK293 cells
that do not express CFTR (unpublished data). Because immu-
noprecipitations were performed on ice, it is likely that the tem-
perature-sensitive phenotype of  F508-CFTR resulted in par-
tial folding after transfer to ice, accounting for the observed
level of recovery of Sec24. Although the band B ER form
would be expected to be the only form of CFTR that would
bind the ER-specific COPII coat machinery, we examined
whether or not immunoprecipitation of Sec24 would recover
band C, the cell surface form. Despite the large excess of band
C in the cell (Fig. 5 A), immunoprecipitation of Sec24 fol-
lowed by immunoblotting for CFTR only recovered the band B
forms of either wild type or  F508 (Fig. 5 B).
To test the ability of the DAA-CFTR mutant to bind the
Sec23/Sec24, we transfected HEK293 cells with wild-type CFTR
or DAA-CFTR using the vaccinia expression system. Strikingly,
we observed that band B of the DAA-CFTR mutant bound  5%
of that recovered in immunoprecipitates with wild-type CFTR
(Fig. 5 B). These results support the conclusion that the marked
inefficiency of DAA-CFTR to exit the ER is a consequence of its
inability to couple to the cargo selection complex Sec23/Sec24.
To correlate the effects of the di-acidic code DAA-CFTR
mutant on COPII binding with the effects of Phe508 on the
ability of the  F508-CFTR to exit the ER after transfer to 30 C,
we performed a temperature-shift experiment. As shown in Fig.
5 D, with increasing incubation time at 30 C,  F508 showed a
strong increase in its interaction with Sec24, approaching the
value observed for wild-type CFTR at 37 C at steady-state.
These results suggest that reduced temperature promotes matu-
ration of CFTR and presentation of the exit code for interaction
with the COPII coat machinery for export from the ER.
Discussion
COPII-dependent export of CFTR
Using Sar1 mutants with well-characterized biochemical proper-
ties, we found that export of wild-type CFTR is dependent on
COPII coat assembly in mammalian cells. This would be the ex-
pected result if wild-type CFTR, but not  F508-CFTR, acquires
the normal protein fold necessary for cargo selection by COPII.
Several lines of evidence support this conclusion. First, the Sar1-
GTP mutant that stabilizes coat assembly markedly reduces the
rate of ERAD through capture into COPII transport intermedi-
ates that accumulate in the presence of activated Sar1 (Aridor et
al., 1995, 1998, 2001). Second, the Sar1-GDP mutant (that pre-
vents COPII coat recruitment) inhibited export of wild-type
CFTR, but did not stabilize the ER band B form. It is unlikely
that the effects of the GDP mutant on CFTR export were influ-
enced by build-up of other cargo in the ER during the transient
expression protocol as we observed inhibition of transport at the
earliest time points of transfection when the inhibitory properties
of the Sar1-GDP mutant begin to take effect. This conclusion is
supported by the ability of H89 to rapidly and efficiently uncou-
ple CFTR from export in cells stably expressing wild-type
CFTR. Furthermore, in the two-stage assay using the Sar1
ts mu-
tant, we found that accumulation of CFTR in the ER at 32 C had
no effect on export after inactivation of Sar1
ts at 40 C. Because
we did not detect significant effects of Sar1-GDP (which uncou-
ples CFTR from COPII) on degradation of CFTR, we suggest
that the export and ERAD pathways operate independently.
COPII does not participate in ERAD
A recent paper (Fu and Sztul, 2003) suggested that targeting of
CFTR to the ERAD pathway in S. cerevisiae requires COPII
because in the absence of COPII function CFTR accumulates
in an ER-like subcompartment rather than being degraded
(Kiser et al., 2001; Fu and Sztul, 2003; Sullivan et al., 2003). In
contrast, we found that COPII does not participate in ERAD of
either wild-type CFTR or  F508-CFTR in mammalian cells.
The reasons for this discrepancy are now apparent. First, CFTR
will not exit the ER in yeast under any condition, limiting inter-
pretation of the results (Kiser et al., 2001; Fu and Sztul, 2003;
Sullivan et al., 2003). Second, all experiments used overex-
pression of a GFP-tagged variant of CFTR (GFP-CFTR). A
similar GFP-CFTR construct, when expressed in mammalian
cells, has a markedly reduced rate of export and accumulates in
ER tubular elements at 30 C (comparable to experiments in
yeast where cells are incubated at 24 C) that significantly over-
laps with calnexin (Fig. S1, available at http://www.jcb.org/
cgi/content/full/jcb.200401035/DC1). This overlap is consis-
tent with the fact that folding of nascent CFTR in the ER is
likely to involve calnexin (Pind et al., 1994). However, upon
transfer to 37 C, GFP-CFTR is efficiently exported to the cell
surface of mammalian cells (Fig. S1). Thus, in mammalian
cells, GFP-CFTR can accumulate transiently in a bona fide ER-
like tubular network at reduced temperature that is unlikely to
be a specialized COPII-regulated degradative subcompartment
as suggested for yeast where export is blocked at all tempera-
tures (Fu and Sztul, 2003; Sullivan et al., 2003).
A third concern is that all experiments relied on tempera-
ture-sensitive COPII mutants to prevent degradation, leading to
the interpretation that COPII is required for ERAD. These ex-
periments required prolonged incubation of yeast at the restric-
tive temperature (40 C) to assess the effect of the mutant
COPII component on ERAD. It is well-established that
elevated temperature (40 ) in mammalian cells markedly
stabilizes (approximately twofold) both wild-type CFTR and
 F508-CFTR from ERAD in response to induction of heat
shock folding chaperones (Strickland et al., 1997; Loo et al.,
1998; Meacham et al., 1999; Choo-Kang and Zeitlin, 2001;
Farinha et al., 2002; unpublished data). Thus, the twofold ef-
fect of the temperature-sensitive Sec12 variant on preventing
CFTR degradation in yeast can be largely explained by the
twofold difference in stability observed upon shift from theJCB • VOLUME 167 • NUMBER 1 • 2004 72
permissive to the restrictive temperature in control incubations
in the absence of the Sec12
ts (Fu and Sztul, 2003).
Fourth, unlike the Sar1-GDP and -GTP mutants, the bio-
chemical properties of the Sec13 and Sec23 temperature-sensi-
tive mutants have not been characterized. For example, both
Sec13 and Sec23 temperature-sensitive variants may not be in-
activated by shifting to the restrictive temperature as suggested
(Fu and Sztul, 2003). Rather they may promote stable coat as-
sembly leading to partial segregation of CFTR from ERAD as
we have observed during COPII coat polymer assembly pro-
moted by the Sar1-GTP mutant. We conclude that role of COPII
is to direct CFTR selection into COPII vesicles, removing the
protein from the ERAD COPII-independent targeted pool.
A di-acidic code mediates CFTR export
An important finding that provides new insight into the role of
COPII in export of CFTR from the ER was that processing of
band B to C was sensitive to mutation of the conserved di-acidic
code exit motif originally detected in the cytoplasmic tail of
VSV-G (Nishimura and Balch, 1997; Nishimura et al., 1999).
Consistent with this finding, a natural variant in the cystic fibro-
sis mutation database (http://www.genet.sickkids.on.ca/cftr/) has
a substitution of G for D at position 565 (
565DAD to 
565GAD) that
results in a severe deficiency phenotype, although this allele is
complex (Tzetis et al., 2001). The requirement for a di-acidic
code in CFTR export is consistent with a similar requirement for
a di-acidic motif for export of the multi-membrane-spanning K
 
channel (Ma et al., 2001; Ma and Jan, 2002) and yeast GAP per-
mease (Malkus et al., 2002) from the ER. Given that transfer of
the di-acidic code to an ER-retained protein is sufficient to pro-
mote efficient export (Nishimura and Balch, 1997; Nishimura et
al., 1999) and the fact that the di-acidic code recognizes the
Sec24 subunit of the Sec23/24 complex (Miller et al., 2002), it is
now evident that the di-acidic motif may be used by CFTR to en-
gage the Sec24. Our CFTR coimmunoprecipitation results pro-
vide direct evidence that the DAD motif in NBD1 of CFTR
serves as a functional ER exit code as loss of the code results in
impaired binding to Sec23/24. In the case of the GAP permease,
it has been suggested that the di-acidic code, although necessary
for export, is not sufficient ((Miller et al., 2002). A similar con-
straint may apply to CFTR as the protein has a complicated cyto-
solic folding pathway involving numerous chaperones and co-
chaperones (Pind et al., 1994; Loo et al., 1998; Brodsky, 2001;
Zhang et al., 2002) that may facilitate recognition of the Sec23/
Sec24 complex (unpublished data).
NBD1 domains of a large variety of ABC transporters have
a similar structural organization (Schmitt and Tampe, 2002).
Structural alignment of the NBD1 domain of CFTR (Lewis et al.,
2004) with the NBD1 domain of the ABC transporter BtuCD re-
veals that the di-acidic code is found in a solvent-exposed loop
connecting the NH2-terminal helical domain containing Phe508
with the more COOH-terminal sheet domain (Fig. 4 A and Fig.
6). Given that the structure of Sar1 and the Sec23/24 complex
containing a bound di-acidic peptide are available (Huang et al.,
2001; Bi et al., 2002; Mossessova et al., 2003), we built a homol-
ogy model with the NBD1 of CFTR replacing the similar struc-
Figure 6. CFTR-COPII cargo selection com-
plex. (bottom) The structure of CFTR-NBD1
(1ROX.pdb) is oriented to show its structural
homology with the NBD1 structural domain
of the bacterial ABC transporter BtuCD
(1L7V.pdb). In CFTR-NBD1, Phe508 is shown
in blue and residues Asp565 and Asp567
(di-acidic code) are shown in yellow. In
BtuCD, the cytosolic domains are shown in
green and putative transmembrane spanning
domains are shown in red. The short loop
shown in red in BtuCD corresponds structurally
to the di-acidic code-containing loop in CFTR-
NBD1. (middle) Homology structure containing
CFTR-NBD1 and BtuCD (Btu-NBD1
CFTR) docked
to the Sar1/Sec23/24 complex (Bi et al.,
2002; Mossessova et al., 2003; see Materials
and methods). Gray rectangle illustrates the
putative location of the membrane bilayer.
(top) The interaction of the CFTR-NBD1 di-acidic
code with the binding pocket of Sec23/24
(Bi et al., 2002; Mossessova et al., 2003).
Shown in blue are Arg230, 235, 559, and
561 basic residues defining the di-acidic code
pocket of Sec24 (Bi et al., 2002; Mossessova
et al., 2003). Only a minor steric interference
is observed between Asp565 (CFTR-NBD1)
and Leu616 (Sec24) in the homology model.
See Fig. S2 for a three-dimensional rendering
of the interface between CFTR-NBD1 and the
Sec23/24 cargo complex. Fig. S2 is avail-
able at http://www.jcb.org/cgi/content/full/
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tural fold of NBD1 of BtuCD (Fig. 6). This new structure
(BtuCD-NBD1
CFTR) was then combined with the structure of the
Sec23/24 -Sar1 complex to illustrate the ability of the di-acidic
code loop in NBD1
CFTR to insert directly into the Sec23/24 di-
acidic code binding pocket (Fig. 6, yellow residues; and Fig. S2
for a three-dimensional view, available at http://www.jcb.org/cgi/
content/full/jcb.200401035/DC1). Docking reveals little steric
interference between residues within the binding pocket, or
between residues defining the tertiary structure of BtuCD-
NBD1
CFTR and the Sar1/Sec24/23 complex. Moreover, the orien-
tation of the NH2 terminus of Sar1 (Fig. 6, red  -strand; residues
25–34), which is linked to the flexible NH2-terminal tail involved
in anchoring Sar1 to the membrane (Fig. 6, black dashed line; not
observed in the crystal structure; Huang et al., 2001; Bi et al.,
2002), is oriented correctly to facilitate recruitment of Sec23/24
by activated Sar1. It is apparent that Sar1 and BtuCD-NBD1
CFTR
interact with Sec23/Sec24 independently as shown for the holo
cargo-selection complex. Thus, the general structural features of
the CFTR-NBD1 domain presented within the structure of BtuCD
are consistent with the role of the di-acidic code in directing in-
teraction with COPII for exit from the ER.
Given the likely importance of the aromatic side-chain of
Phe508 in stabilizing the conserved structural fold of the NH2-
terminal helical domain of NBD1 (Fig. 6, blue residue), deletion
of Phe508 in the  F508-CFTR mutant may alter the orientation
of the di-acidic motif-containing loop, thereby compromising its
interaction with Sec24. This notion was directly tested by the
CFTR coimmunoprecipitation experiments where we found that
binding of band B of  F508 to Sec24 was much lower than that
of wild-type CFTR. Consistent with this interpretation,  F508-
CFTR-Sec24 interaction and transport to cell surface can be res-
cued by promoting folding at 30 C. Moreover, export of  F508-
CFTR from the ER can also be rescued in cis by additional point
mutations in NBD1 that stabilize the structural fold (DeCar-
valho et al., 2002). Given that over 1,000 mutants have been re-
ported to affect CFTR export and function leading to varying
degrees of disease, it is not surprising that residues flanking the
di-acidic code have also been reported in the mutation database.
Structural considerations strongly suggest that many of these
flanking mutations, unlike the di-acidic code that is found in the
solvent-exposed loop, are likely to affect the fold of the  -heli-
cal and  -strands that contribute to the structural organization of
NBD1 and indirectly compromise presentation of the code (un-
published data). We propose that the inability of the  F508-
CFTR mutant to engage the COPII machinery through Sec24 is
the primary basis for the most common form of CF.
Materials and methods
Materials
Reagents for vaccinia transient expression were prepared as described
previously (Yoo et al., 2002). HEK293 stably expressing wild-type CFTR
and   F508-CFTR were obtained from N. Bradbury (University of Pitts-
burgh School of Medicine, Pittsburgh, PA). The M3A7 antibody was pro-
vided by J. Riordan (Mayo Clinic, Scottsdale, AZ).
Vaccinia transient expression
Vaccinia transient expression and quantification was performed exactly as
described previously (Yoo et al., 2002). SEM were determined using the
software program Prism.
Immunoprecipitation of the CFTR-Sec24 complex
HEK293 cells stably expressing wild-type CFTR or  F508-CFTR, or vac-
cinia-transfected HEK293 cells transiently expressing wild-type CFTR and
DAA-CFTR were lysed on ice in Triton X-100 lysis buffer (50 mM Tris-HCl,
pH 7.4, 150 mM NaCl, and 1% Triton X-100) supplemented with com-
plete protease inhibitor cocktail tablets (Roche Diagnostics GmbH). Solu-
ble fraction of the lysates were incubated with protein G beads coupled
with anti-CFTR antibody M3A7 or anti-Sec24 polyclonal antibodies. The
immunocomplexes were washed and eluted with 50 mM Tris-HCl, pH 6.8,
and 1% SDS. The protein components of the complexes were separated
by SDS-PAGE. CFTR and Sec24 were detected by immunoblot. CFTR and
Sec24 were quantitated by densitometry using a Molecular Dynamics Im-
aging System. In brief, for CFTR detected by immunoblotting, immunoblots
exposed in the linear range were quantitated by measuring the densities
of band B or C. A similar area immediately adjacent to bands B or C in
each lane (background) were subtracted from the B or C value to obtain
the indicated values shown in the Results.
Structural alignment of CFTR-NBD1, BtuCD, and the Sec23/24 complex
Fitting of CFTR-NBD1 to BtuCD and Sec23/24 was performed as follows. The
Sec24/NBD1 complex model was built from the Sec24/DXE peptide com-
plex (1PD1.pdb) and NBD1 (1R0X.pdb) coordinates by superimposing DXE
peptide onto the corresponding part of NBD1. The Sec24/NBD1/Sec23
complex model was built from the Sec24/NBD1 model and Sec24/Sec23
complex (1M2V.pdb) by superimposing Sec24 in both coordinates. The
Sec24/NBD1/Sec23/Sar1 complex model was built from Sec24/NBD1/
Sec23 model and Sec23/Sar1 complex (1M2O.pdb) by superimposing
Sec23 in both coordinates. The Sec24/NBD1/Sec23/Sar1/BtuCD complex
model was built from the Sec24/NBD1/Sec23/Sar1 model and BtuCD
(1L7V.pdb) by superimposing CFTR-NBD1 and BtuD in both coordinates. Fit-
ting was performed using the McLachlan algorithm (McLachlan, 1982) as im-
plemented in the program ProFit (http://www.bioinf.org.uk/software/).
Online supplemental material
Fig. S1 shows GFP-CFTR accumulates in the ER at 28 C. Fig. S2 is a three-
dimensional rendering of CFTR-NBD1 di-acidic code docked to the Sar1/
Sec23/24 cargo selection complex. Online supplemental material is avail-
able at http://www.jcb.org/cgi/content/full/jcb.200401035/DC1.
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